Ecuador vs Morocco: Treatment success rate for patients treated for MDR-TB
Ecuador
65.0%
in 2022
Morocco
66.0%
in 2022
Ecuador rank
113th
Morocco rank
112th
Treatment success rate for patients treated for MDR-TB over time
- Ecuador
- Morocco
How they compare
Morocco currently reports 66.0% against 65.0% in Ecuador, a difference of 1.0%.
The two have swapped places 3 times across 14 shared years of data; in 2004 it was Ecuador ahead.
Ecuador ranks 113th and Morocco ranks 112th of 163 countries.
Across the 3 decades both report, Ecuador averaged higher in 2 and Morocco in 1.
Head to head by decade
| Decade | Ecuador | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.0% | 38.0% | 23.0% | Ecuador |
| 2010s | 48.7% | 44.9% | 3.9% | Ecuador |
| 2020s | 53.0% | 66.0% | 13.0% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Ecuador or Morocco?
- Morocco, at 66.0% against 65.0% in Ecuador as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Ecuador and Morocco?
- 1.0%, with Morocco ahead.
- How many years of comparable data are there for Ecuador and Morocco?
- 14 years are reported by both, from 2004 to 2022.
- How do Ecuador and Morocco rank globally for treatment success rate for patients treated for mdr-tb?
- Ecuador ranks 113th and Morocco ranks 112th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.